Kronos Bio Inc.

NASDAQ: KRON · Real-Time Price · USD
0.88
0.01 (1.49%)
At close: Jun 20, 2025, 9:43 AM

Kronos Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
9.19M 9.85M 9.86M 8.41M 7.59M 6.29M 4M 3.08M 1.22M n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a 478K 988K 2.17M 3.32M 3.99M 4.63M 4.59M 4.53M 4.55M 4.29M 4.27M 4.08M 2.92M 2.02M 905K
Gross Profit
9.19M 9.85M 9.39M 7.42M 5.42M 2.97M 16K -1.54M -3.37M -4.53M -4.55M -4.29M -4.27M -4.08M -2.92M -2.02M -905K
Operating Income
-70.33M -80.1M -80.29M -98.4M -112.55M -121.83M -128.17M -127.88M -129.24M -137.12M -165.84M -165.97M -161.59M -151.4M -110.08M -97.22M -76.87M
Interest Income
5.85M 6.81M 7.49M 8.33M 8.94M 9.16M 9.03M 7.86M 6.06M 3.91M 2.08M 871K 330K 320K 372K 502K 635K
Pretax Income
-64.48M -86.08M -85.59M -102.85M -116.39M -112.67M -119.14M -120.02M -123.18M -133.2M -163.76M -165.1M -161.25M -151.08M -121.9M -128.01M -107.53M
Net Income
-64.48M -86.08M -85.59M -102.85M -116.39M -109.85M -113.68M -113.28M -115.82M -128.56M -161.75M -164.37M -161.15M -151.08M -121.9M -128.01M -107.53M
Selling & General & Admin
23.23M 24.62M 30.62M 34.2M 39.19M 41.74M 41.33M 42.06M 41.53M 43.4M 44.47M 43.32M 41.84M 38.49M 34.87M 29.94M 22.22M
Research & Development
36.56M 48.66M 58.48M 71.56M 80.47M 85.9M 90.84M 88.9M 88.94M 93.72M 121.37M 122.65M 119.75M 112.9M 75.21M 67.28M 54.65M
Other Expenses
19.74M 29.45M 13.36M 13.36M 12.79M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
79.53M 102.73M 102.46M 119.12M 132.44M 127.64M 132.17M 130.97M 130.46M 137.12M 165.84M 165.97M 161.59M 151.4M 110.08M 97.22M 76.87M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.89M 3.89M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
79.53M 102.73M 102.94M 119.6M 132.92M 128.12M 132.17M 130.97M 130.46M 137.12M 165.84M 165.97M 161.59M 151.4M 110.08M 97.22M 76.87M
Income Tax Expense
n/a 1.23M 1.23M 1.23M 1.23M -2.82M -5.45M -6.74M -7.36M -4.64M -2.48M -1.13M -420K -226K 248K 178K 92K
Shares Outstanding (Basic)
60.81M 60.34M 60.31M 60.1M 59.52M 58.27M 58.15M 57.4M 57.15M 56.52M 56.32M 56.12M 55.84M 55.36M 54.98M 54.51M 54.15M
Shares Outstanding (Diluted)
60.81M 60.34M 60.31M 60.1M 59.52M 58.27M 58.15M 57.4M 57.15M 56.52M 56.32M 56.12M 55.84M 55.36M 54.98M 54.51M 54.15M
EPS (Basic)
-1.07 -1.43 -1.43 -1.74 -1.99 -1.9 -1.99 -2 -2.06 -2.3 -2.91 -2.97 -2.92 -2.75 -2.32 -2.44 -2.08
EPS (Diluted)
-1.07 -1.43 -1.43 -1.74 -1.99 -1.9 -1.99 -2 -2.06 -2.3 -2.91 -2.97 -2.92 -2.75 -2.32 -2.44 -2.08
EBITDA
-49.14M -61.72M -75.9M -93.92M -105.45M -114.64M -122.91M -122.56M -126.97M -134.85M -162.91M -163.09M -158.81M -148.73M -118.39M -119.89M -99.82M
EBIT
-50.6M -63.43M -79.71M -97.82M -109.63M -118.91M -125.25M -124.97M -129.24M -137.12M -165.77M -165.9M -161.51M -151.33M -122.15M -124.3M -103.74M
Depreciation & Amortization
1.46M 2.51M 2.58M 2.68M 3.44M 3.32M 3.99M 4.63M 4.59M 4.53M 4.55M 4.29M 4.27M 4.08M 3.22M 2.52M 1.58M